Cargando…
The bromodomain inhibitor JQ1+ reduces calcium-sensing receptor activity in pituitary cell lines
Corticotrophinomas represent 10% of all surgically removed pituitary adenomas, however, current treatment options are often not effective, and there is a need for improved pharmacological treatments. Recently, JQ1+, a bromodomain inhibitor that promotes gene transcription by binding acetylated histo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345903/ https://www.ncbi.nlm.nih.gov/pubmed/34223822 http://dx.doi.org/10.1530/JME-21-0030 |